tility of Manual Acupressure in Allergic Rhinitis
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2024/03/064405
- Lead Sponsor
- JIPMER Intramural Research Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Between the ages of 18 and 50 years
2. Clinically diagnosed as allergic rhinitis, as per ARIA guidelines and using Absolute Eosinophil Count
3. Symptom duration for more than 6 months
4. Moderate to severe allergic rhinitis (Visual Analogue Scale score of 30-70mm at baseline)
5. Symptoms severe enough to require oral antihistamines/intranasal corticosteroid usage
1. Pediatric patients, less than 18 years of age
2. Patients with anatomical abnormality of nose (Deviated nasal septum, Concha bullosa etc)
3. Patients with diagnosed asthma or other chronic upper respiratory pathologies, parasitic infestations or immunological diseases
4. Pregnant and breastfeeding women
5. Patients on steroids or other immunosuppressive therapy for unrelated conditions
6. Patients using other complementary medicine systems during the study period
7. Contra-indication to cetirizine or inhalational steroid therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in scores of quality of life questionnaires: NRQLQ, VAS, TNSSTimepoint: Improvement in scores of quality of life questionnaires: NRQLQ, VAS, TNSS at baseline, 4 weeks and 6 weeks
- Secondary Outcome Measures
Name Time Method Reduction in total serum human immunoglobulin E (IgE)Timepoint: 6 weeks